Net profit of Nectar Lifescience rose 82.02% to Rs 14.27 crore in the quarter ended December 2025 as against Rs 7.84 crore during the previous quarter ended December 2024. There were no Sales reported in the quarter ended December 2025 and during the previous quarter ended December 2024.Powered by Capital Market - Live News

Nectar Lifescience will hold a meeting of the Board of Directors of the Company on 23 January 2026.Powered by Capital Market - Live News

Nectar Lifescience will hold a meeting of the Board of Directors of the Company on 3 December 2025.Powered by Capital Market - Live News

Net loss of Nectar Lifescience reported to Rs 176.01 crore in the quarter ended September 2025 as against net profit of Rs 5.60 crore during the previous quarter ended September 2024. Sales declined 12.74% to Rs 5.00 crore in the quarter ended September 2025 as against Rs 5.73 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales5.005.73 -13 OPM %-6.60-10.30 - PBDT-0.300.10 PL PBT-0.50-0.35 -43 NP-176.015.60 PL Powered by Capital Market - Live News

Nectar Lifescience will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live News